Guangdong Provincial People's Hospital

This study tests a new CPR method called Bio-CPR, which combines chest compressions with breathing support in a more natural way. It involves 408 adults who have a witnessed cardiac arrest outside the hospital. The goal is to see if Bio-CPR works better than standard CPR to impro…

This study tests a new way to deliver treatment directly to the abdomen for people with advanced stomach cancer that has spread to the lining of the belly. It compares a virus-based therapy (VRT106) given as a pressurized spray during keyhole surgery against standard chemotherapy…

This study tests a new treatment plan for people with a certain type of lung cancer (KRAS G12C mutation) that can be removed with surgery. Before and after surgery, patients will receive a combination of targeted therapy (glesorasib), immunotherapy (ivonescimab), and chemotherapy…

This study tests whether a procedure that closes off a small heart pouch (left atrial appendage occlusion) combined with a heart-rhythm correction (catheter ablation) is safer and more effective than ablation plus daily blood thinners for frail patients aged 75 and older with atr…

This study tests a new approach for adults with locally advanced rectal cancer that hasn't spread. Participants get a short course of radiation followed by a mix of two chemotherapy drugs and an immunotherapy drug. The goal is to shrink the tumor enough so that surgery may not be…

This study tests a special scanner that uses fluorescence to help surgeons see if any cancer cells are left behind during breast-conserving surgery. About 172 women with breast cancer will take part. The goal is to see if this tool reduces the need for a second surgery by finding…

This study looks at whether hyperbaric oxygen therapy can reduce nerve pain and numbness caused by a common chemotherapy drug (nab-paclitaxel) in breast cancer patients. About 160 women who have finished chemo and developed nerve symptoms will receive either oxygen therapy or sta…

This study looks at whether measuring CEA and ctDNA in the blood can help predict if lung cancer will return after surgery. Researchers will follow 100 patients with high CEA levels before surgery, tracking their blood markers for two years. The goal is to catch recurrence earlie…